Edsivo
Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome
June 26, 2019Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma
Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …
